Satellos Bioscience Inc.
MSCL
주식 순위
#17768
Satellos Bioscience Inc., a biotechnology firm established in 2018 and... Satellos Bioscience Inc., a biotechnology firm established in 2018 and headquartered in Toronto, Canada, specializes in developing regenerative therapies for degenerative muscle diseases. The company primarily operates in Canada and Australia, utilizing its proprietary MyoReGenX platform – an automated microscopy system engineered to replicate the muscle stem cell environment outside the body. A key focus for Satellos is the discovery and development of a small molecule drug specifically aimed at treating Duchenne muscular dystrophy.
주가
$10.22
마지막 동기화: 2026-07-31
시가총액
$212.97M
변동 (1일)
4.58%
변동 (1년)
2,278.10%
국가
CA
거래 Satellos Bioscience Inc. (MSCL)
카테고리
Healthcare
Satellos Bioscience Inc. (MSCL)의 주가 이력
최고 종가: $0.48 (2024-03-01 기준)
최저 종가: $12.71 (2008-01-01 기준)
최저 종가: $12.71 (2008-01-01 기준)
Satellos Bioscience Inc.의 주가 이력 (2008 ~ 2026)
연간 주가 성과
| 연도 | 성과 |
|---|---|
| 2024 | 43.42% |
| 2023 | 91.27% |
| 2022 | -80.10% |
| 2021 | 2.79% |
| 2020 | -11.41% |
| 2019 | 10.94% |
| 2018 | 37.66% |
| 2017 | -27.41% |
| 2016 | 41.02% |
| 2015 | -8.55% |
| 2014 | -90.26% |
| 2013 | -52.35% |
| 2012 | 195.82% |
| 2011 | -36.68% |
| 2010 | -30.40% |
| 2009 | 333.63% |
| 2008 | 0.00% |
유사 기업 또는 경쟁사의 주가
| 회사 | 주가 | 변동률 1년% | 국가 |
|---|---|---|---|
| $527.18 | 23.67% |
US
|
|
| $251.29 | 814.11% |
US
|
|
| $136.62 | -4.51% |
AU
|
|
| $890.85 | 6.72% |
NL
|
|
| $752.87 | 7.40% |
CH
|
